Business
Retinal Disease Expert Dr. Taiji Sakamoto Joins Kiora Pharmaceuticals' Scientific Advisory Board
Encinitas, California--(Newsfile Corp. - January 27, 2026) - Kiora Pharmaceuticals (NASDAQ: KPRX) has appointed leading retina specialist, Dr. Taiji Sakamoto, an expert in the treatment of retinal disease, to its Scientific Advisory Board. As an advisor, Dr. Sakamoto, currently the Chair of Ophthalmology at Kagoshima University, will contribute clinical and scientific insights to Kiora as it develops new therapeutics to address retinal diseases with high unmet needs. "As we deepen our...
About this update from Kiora Pharmaceuticals, Inc.
[{"type":"text","content":"Encinitas, California--(Newsfile Corp. - January 27, 2026) - Kiora Pharmaceuticals (NASDAQ: KPRX) has appointed leading retina specialist, Dr. Taiji Sakamoto, an expert in the treatment of retinal disease, to its Scientific Advisory Board. As an advisor, Dr. Sakamoto, currently the Chair of Ophthalmology at Kagoshima University, will contribute clinical and scientific insights to Kiora as it develops new therapeutics to address retinal diseases with high unmet needs.","length":471,"tagName":"p"},{"type":"text","content":""As we deepen our understanding of inflammatory pathways in retinal disease, it is increasingly important to pursue therapeutic options that do not rely on chronic steroid use," explained Dr. Sakamoto. "Non-steroidal approaches such as KIO-104 represent an important direction for the field, aiming to manage inflammation while avoiding many of the limitations associated with steroids. I look forward to contributing to the advancement of these efforts as part of Kiora's Scientific Advisory Board."","length":524,"tagName":"p"},{"type":"text","content":"Dr. Sakamoto's research and clinical interests involve diabetic retinopathy, retinal surgery and ocular angiogenesis. He developed triamcinolone-assisted vitrectomy and the Japan-Retinal Detachment Registry. He has published more than 460 peer-reviewed papers with an h-index of 62 as of June 2025. Additionally, he developed an AI based OCT-algorithm, which is installed with several commercial machines. He is currently a Co-Editor-in-Chief of Graefe's Archives of Ophthalmology, and Editor-in-Chief of JRVS Times.","length":524,"tagName":"p"},{"type":"text","content":""We welcome Dr. Taiji Sakamoto, a leading retina specialist, to Kiora's Scientific Advisory Board," added Eric Daniels, MD, MBA, Chief Development Officer of Kiora. "His extensive expertise in retinal disease and clinical research will provide valuable guidance as we continue advancing our development programs. We look forward to his contributions as we work to bring meaningful solutions to patients."","length":428,"tagName":"p"},{"type":"text","content":"Dr. Taiji Sakamoto graduated from Kyushu University, Japan in 1985. He completed his residency and proceeded to attain fellowships in ophthalmology at Kyushu University, Japan. He then moved to the D...